Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Ann Surg. 2019 Sep;270(3):502–510. doi: 10.1097/SLA.0000000000003458

Table 4.

Post-sepsis mortality

Sepsis cohort (n=301)
Early Death (< 14 days) 13/301 (4.3%)
  MOF 8 (62%)
  End-stage vascular disease 3 (23%)
  Respiratory failure/ARDS 2 (15%)
Involved withdrawal of care 9/13 (69%)
30-day mortality 29/301 (9.6%)
  MOF 17 (59%)
  End-stage vascular disease 4 (14%)
  Respiratory failure/ARDS 2 (7%)
  Heart failure 1 (3%)
Involved withdrawal of care 23/29 (79%)
>30-day mortality (late deaths) 34/301 (11.3%)
  Late MOF 8 (24%)
  End-stage cancer 7 (21%)
  Sepsis (recurrent) 7 (21%)
  Heart failure/MI 5 (15%)
  End-stage vascular disease 3 (9%)
  Renal Failure 2 (6%)
  CVA 2 (6%)
  Unknown 2 (6%)
Involved withdrawal of care 18/34 (53%)
Overall 12-month mortality 63/301 (20.9%)
  Late MOF (not infection related) 23 (37%)
  Sepsis (recurrent) 12 (32%)
  End-stage cancer 7 (11%)
  End-stage vascular disease 7 (11%)
  Heart failure/MI 6 (10%)
  Respiratory failure 2 (3%)
  Renal failure 2 (3%)
  CVA 2 (3%)
  Unknown 2 (3%)
Involved withdrawal of care 41/63 (65%)